Evidence map›Paper›PMID 41596653›Full record

ArticleInternational journal of molecular sciences2026

Design, Synthesis, and Biological Evaluation of Novel Acetylcholinesterase and β-Secretase 1 Inhibitors.

Danuta Drozdowska, Damian Pawelski, Agnieszka Wróbel-Tałałaj, Marta Plonska-Brzezinska, Beata Kolesinska, Ryszard Lazny, Barbara Seroka, Cezary Parzych, Artur Ratkiewicz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danuta DrozdowskaDepartment of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-3479-0480
Damian PawelskiDepartment of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0003-3878-8588
Agnieszka Wróbel-TałałajDepartment of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0003-4493-1547
Marta Plonska-BrzezinskaDepartment of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0002-0538-6059
Beata KolesinskaInstitute of Organic Chemistry, Lodz University of Technology, 90-924 Lodz, Poland.ORCID 0000-0002-4581-947X
Ryszard LaznyDepartment of Polymers and Organic Synthesis, Faculty of Chemistry, University of Bialystok, 15-245 Bialystok, Poland.ORCID 0000-0003-2358-0960
Barbara SerokaDepartment of Polymers and Organic Synthesis, Faculty of Chemistry, University of Bialystok, 15-245 Bialystok, Poland.ORCID 0000-0002-2157-4180
Cezary ParzychDepartment of Physical Chemistry, Faculty of Chemistry, University of Bialystok, 15-245 Bialystok, Poland.ORCID 0009-0003-6756-3350
Artur RatkiewiczDepartment of Physical Chemistry, Faculty of Chemistry, University of Bialystok, 15-245 Bialystok, Poland.ORCID 0000-0003-1657-1871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel granatane-triazole hybrid molecules was designed, synthesized, and evaluated as dual acetylcholinesterase (AChE) and β-secretase 1 (BACE1) inhibitors. The compounds were obtained through a convergent synthetic route involving azide formation, triazole construction via dipolar cycloaddition, and final coupling with a granatane scaffold to give a pseudopelletierine (3-granatanone) analogue. In vitro assays demonstrated that all target compounds inhibited both AChE and BACE1. Molecular docking and molecular dynamics simulations revealed stable interactions with key catalytic residues, suggesting distinct binding modes compared to reference ligands. QSAR-based pharmacokinetic predictions indicated favorable blood-brain barrier permeability and compliance with key drug-likeness filters. These findings identify granatane-triazole hybrids as promising multi-target directed ligand (MTDL) candidates with potential for further optimization in the search for new anti-Alzheimer therapeutics.

Indexed as

AcetylcholinesteraseAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesCholinesterase InhibitorsDrug DesignHumansMolecular Docking SimulationMolecular Dynamics SimulationQuantitative Structure-Activity RelationshipTriazolesAcetylcholinesteraseAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanCholinesterase InhibitorsTriazoles3-granatanoneAlzheimer’s diseaseBACE1 inhibitorscholinesterase inhibitorsenzyme inhibitorsmulti-target drugspseudopelletierine

Identifiers

PMID41596653
PMCPMC12842540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.